At least 25 people at nursing homes get experimental covid preventive drug
Big Pharma firm Eli Lilly is testing whether its experimental antibody drug can stop a single infection from turning into a full-blown outbreak in US nursing homes. The company is running trials of its highly-anticipated monoclonal antibody treatment in a highly unusual study population: elderly Americans in long-term care facilities. Monoclonal antibodies are modeled after … Read more